HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A predictive model for the clearance of soluble phospholipase A2 during septic shock.

Abstract
Circulating phospholipase A2 (PLA2) has been recognized as a mediator of cardiovascular collapse in septic shock. Proximal mediators of endotoxemia, including tumor necrosis factor and interleukin 1, induce PLA2 synthesis and release, but the factors regulating PLA2 elimination are unknown. Similarly, the kinetics of PLA2 clearance during recovery from septic shock have not been examined. An autoregressive mathematical model was developed to describe the rate of PLA2 clearance during the recovery phase of septic shock. This model (which estimates that the current day's PLA2 level is 77% of the previous day's level), accounted for 89% of the variability seen in the data. The estimated circulating half-life of soluble PLA2 in septic shock in man was 32 hours. Since elevation in serum PLA2 activity is closely associated with bacteremia or endotoxemia, a significant deviation from predicted PLA2 values may denote impending relapse.
AuthorsP Vadas, W Pruzanski, V Farewell
JournalThe Journal of laboratory and clinical medicine (J Lab Clin Med) Vol. 118 Issue 5 Pg. 471-5 (Nov 1991) ISSN: 0022-2143 [Print] United States
PMID1940588 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Phospholipases A
  • Phospholipases A2
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Bacteremia (blood)
  • Female
  • Half-Life
  • Humans
  • Male
  • Mathematics
  • Middle Aged
  • Models, Biological
  • Phospholipases A (blood, pharmacokinetics)
  • Phospholipases A2
  • Predictive Value of Tests
  • Shock, Septic (epidemiology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: